Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors
    1.
    发明申请
    Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors 审中-公开
    小分子噻吩并嘧啶类蛋白酪氨酸激酶抑制剂

    公开(公告)号:US20060004002A1

    公开(公告)日:2006-01-05

    申请号:US10884224

    申请日:2004-07-02

    CPC分类号: C07D495/04

    摘要: Various thienopyrimidine-based analog compounds are able to selectively inhibit the Src family of tyrosine kinases. These compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections.

    摘要翻译: 各种基于噻吩并嘧啶的类似物能够选择性地抑制酪氨酸激酶的Src家族。 这些化合物可用于治疗各种疾病,包括过度增生性疾病,血液病,骨质疏松症,神经系统疾病,自身免疫性疾病,过敏性/免疫性疾病或病毒性感染。

    Cobalt(II) complexes as protein tyrosine kinase inhibitors
    3.
    发明申请
    Cobalt(II) complexes as protein tyrosine kinase inhibitors 审中-公开
    钴(II)配合物作为蛋白酪氨酸激酶抑制剂

    公开(公告)号:US20060003980A1

    公开(公告)日:2006-01-05

    申请号:US10884067

    申请日:2004-07-02

    IPC分类号: C07F15/06 A61K31/555

    CPC分类号: C07F15/065

    摘要: Various cobalt (II) complexes are able to selectively inhibit the protein tyrosine kinases (PTKs). These complexes are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections.

    摘要翻译: 各种钴(II)配合物能够选择性地抑制蛋白酪氨酸激酶(PTK)。 这些复合物可用于治疗各种疾病,包括过度增生性疾病,血液病,骨质疏松症,神经系统疾病,自身免疫性疾病,过敏性/免疫性疾病或病毒性感染。